After collecting more than 2 million people’s DNA and winning hard-fought federal clearances to sell certain health tests, 23andMe has big plans — including using its customers’ genetic data to develop drugs of its own. To get there, it’s raised $250 million in a round led by powerhouse venture capital firm Sequoia Capital, the company announced today.

23andMe, which extracts genetic information about your health, ancestry, and physical traits from mail-home saliva kits, has now raised a total of $491 million. TechCrunch first reported that the company was raising its first round since 2015. The latest round’s pre-money valuation was $1.5 billion, according to Axios. (A spokesperson declined to comment on valuation.)

The new influx of capital indicates that 23andMe doesn’t plan to go public in the near future, despite launching more than a decade ago, in 2006.

Under its CEO and cofounder Anne Wojcicki, the Silicon Valley startup has been working for two years to create therapeutics based on genetic targets found in its massive customer database. That team, made up of Genentech veteran Richard Scheller and 40 employees, works out of a lab in South San Francisco separate from 23andMe’s headquarters, Emily Drabant Conley, vice president of business development, told BuzzFeed News. She said the team is investigating oncology and disorders of the skin, immune system, liver, and heart.

23andMe’s future success depends on it expanding its database. The more DNA it collects and the more surveys customers answer about their health and lifestyles, the more data 23andMe has to develop drugs internally. It also has more to offer big-name pharmaceutical companies like Pfizer and Genentech, which pay to access much of that information. (About 85% of 23andMe’s customers opt in to letting the company use their data for research, the company says.)

“It’s one-of-a-kind in the world,” Drabant Conley said. “We’re the largest database of genetic information and health information together.” In just the last few weeks, she noted, this database was the basis for publications about pre-term births and Parkinson’s disease in high-profile scientific journals. A month ago, 23andMe and the pharmaceutical company Lundbeck started recruiting 25,000 customers to participate in a study on depression and bipolar disorders; Drabant Conley says they’re nearly done.

So Drabant Conley said that the new funding will also be spent on advertising and recruiting new customers. And what helps 23andMe stand apart from the now-dozens of personal genetic-testing companies in existence is that it’s the only one that can tell people about their health risks without going through a doctor or a genetic counselor.

In 2013, the FDA banned 23andMe from telling customers their risks for 254 diseases and conditions. Two years later, the company got clearance to provide health information again, but to a much more limited extent, for about 36 relatively rare genetic diseases. And this April, the company won yet another victory when the agency agreed to allow reports for 10 more diseases, including serious ones like Alzheimer’s and Parkinson’s.

“It’s been game-changing,” Drabant Conley told BuzzFeed News when asked how customers have responded to the approvals. “The FDA clearances enable us to provide the information that is most valuable to consumers. The genetic health risks are things consumers really care about.”

23andMe also announced that two directors are joining its board, bringing its member total to five: Roelof Botha, a partner at Sequoia Capital, and Neal Mohan, chief product officer for YouTube and a Google senior vice president, who joined in July. (It’s worth noting that Wojcicki’s sister Susan is the CEO of YouTube.)

Over the last year, a handful of executives have departed 23andMe, including president Andy Page (now CEO of diabetes startup Livongo). A spokesperson said the company does not plan to replace him at this time. 23andMe also let go of a team last summer dedicated to next-generation sequencing, even as competing startups are making the technology a core part of their business.

Share on Twitter
Share on Twitter
Twitter
Share on Facebook
Share on Facebook
Facebook
Share on System
Share on System
System

We value your privacy

We and our partners use technology such as cookies on our site to personalize content and ads, provide social media features, and analyze our traffic. Click below to consent to the use of this technology across the web. You can change your mind and change your consent choices at anytime by returning to this site.

BuzzFeed

Information storage and access

The storage of information, or access to information that is already stored, on your device such as advertising identifiers, device identifiers, cookies, and similar technologies.

Personalisation

The collection and processing of information about your use of this service to subsequently personalise advertising and/or content for you in other contexts, such as on other websites or apps, over time. Typically, the content of the site or app is used to make inferences about your interests, which inform future selection of advertising and/or content.

Ad selection, delivery, reporting

The collection of information, and combination with previously collected information, to select and deliver advertisements for you, and to measure the delivery and effectiveness of such advertisements. This includes using previously collected information about your interests to select ads, processing data about what advertisements were shown, how often they were shown, when and where they were shown, and whether you took any action related to the advertisement, including for example clicking an ad or making a purchase. This does not include personalisation, which is the collection and processing of information about your use of this service to subsequently personalise advertising and/or content for you in other contexts, such as websites or apps, over time.

Content selection, delivery, reporting

The collection of information, and combination with previously collected information, to select and deliver content for you, and to measure the delivery and effectiveness of such content. This includes using previously collected information about your interests to select content, processing data about what content was shown, how often or how long it was shown, when and where it was shown, and whether the you took any action related to the content, including for example clicking on content. This does not include personalisation, which is the collection and processing of information about your use of this service to subsequently personalise content and/or advertising for you in other contexts, such as websites or apps, over time.

Third-party vendors

Information storage and access

The storage of information, or access to information that is already stored, on your device such as advertising identifiers, device identifiers, cookies, and similar technologies.

View CompaniesHide Companies

Company

Lotame Solutions, Inc.

OpenX Software Ltd. and its affiliates

The Rubicon Project, Limited

Index Exchange, Inc.

comScore, Inc.

DoubleVerify Inc.​

LiveRamp, Inc.

Taboola Europe Limited

PubMatic, Inc.

Outbrain UK Ltd

EMX Digital LLC

Nielsen Marketing Cloud

Google (DFP / AdX)

Personalisation

The collection and processing of information about your use of this service to subsequently personalise advertising and/or content for you in other contexts, such as on other websites or apps, over time. Typically, the content of the site or app is used to make inferences about your interests, which inform future selection of advertising and/or content.

View CompaniesHide Companies

Company

Lotame Solutions, Inc.

OpenX Software Ltd. and its affiliates

LiveRamp, Inc.

Outbrain UK Ltd

EMX Digital LLC

Nielsen Marketing Cloud

Google (DFP / AdX)

Ad selection, delivery, reporting

The collection of information, and combination with previously collected information, to select and deliver advertisements for you, and to measure the delivery and effectiveness of such advertisements. This includes using previously collected information about your interests to select ads, processing data about what advertisements were shown, how often they were shown, when and where they were shown, and whether you took any action related to the advertisement, including for example clicking an ad or making a purchase. This does not include personalisation, which is the collection and processing of information about your use of this service to subsequently personalise advertising and/or content for you in other contexts, such as websites or apps, over time.

View CompaniesHide Companies

Company

Lotame Solutions, Inc.

OpenX Software Ltd. and its affiliates

LiveRamp, Inc.

Outbrain UK Ltd

Google (DFP / AdX)

Content selection, delivery, reporting

The collection of information, and combination with previously collected information, to select and deliver content for you, and to measure the delivery and effectiveness of such content. This includes using previously collected information about your interests to select content, processing data about what content was shown, how often or how long it was shown, when and where it was shown, and whether the you took any action related to the content, including for example clicking on content. This does not include personalisation, which is the collection and processing of information about your use of this service to subsequently personalise content and/or advertising for you in other contexts, such as websites or apps, over time.

View CompaniesHide Companies

Company

Lotame Solutions, Inc.

LiveRamp, Inc.

Google (DFP / AdX)

Measurement

The collection of information about your use of the content, and combination with previously collected information, used to measure, understand, and report on your usage of the service. This does not include personalisation, the collection of information about your use of this service to subsequently personalise content and/or advertising for you in other contexts, i.e. on other service, such as websites or apps, over time.